Gastric Inhibitory Polypeptide (GIP) Antibody
260€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Gastric Inhibitory Polypeptide (GIP) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx128739
Tested Applications
WB, IHC, IF/ICC
Description
Gastric Inhibitory Polypeptide Antibody is a Rabbit Polyclonal against Gastric Inhibitory Polypeptide.
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: Gastric Inhibitory Polypeptide (GIP) Immunogen: GIP (Glu22-Arg153) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P09681 |
| Alias | Glucose-dependent insulinotropic polypeptide,Incretin |
| Background | Antibody anti-GIP |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
GIP, also called glucose-dependent insulinotropic polypeptide, is a 42-amino acid hormone secreted by K-cells in the duodenum and jejunum in response to nutrient ingestion, particularly glucose, fats, and amino acids GIP acts as a critical incretin hormone that enhances glucose-dependent insulin secretion from pancreatic β-cells by activating cAMP-dependent pathways and protein kinase A signaling GIP also regulates lipid metabolism by stimulating lipoprotein lipase activity in adipose tissue, promoting triglyceride uptake and energy storage GIP further supports bone homeostasis by enhancing osteoblast function, contributing to bone formation and mineralization Dysregulation of GIP levels and signaling is associated with insulin resistance, obesity, and type 2 diabetes where its insulinotropic effects are impaired despite elevated circulating levels GIP-based therapies, including dual GIP/GLP-1 receptor agonists, have shown therapeutic potential in improving glycemic control and promoting weight loss in metabolic disorders
Productos relacionados
Gastric Inhibitory Polypeptide (GIP) Antibody
GIP Antibody is a Rabbit Polyclonal antibody against GIP. This gene encodes an incretin hormone and belongs to the gluca…
Ver producto
Low Sample Volume Rat Gastric Inhibitory Polypeptide (GIP) ELISA Kit
Low Sample Volume Rat Gastric Inhibitory Polypeptide (GIP) ELISA Kit is an ELISA Kit for the in vitro quantitative measu…
Ver producto Gastric Inhibitory Polypeptide (GIP) Antibody
Gastric Inhibitory Polypeptide Antibody is a Rabbit Polyclonal against Gastric Inhibitory Polypeptide.…
Ver producto